Clinical trial

Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer

NCT05177432

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-12-06

PhasePHASE1

Study timeline

Study start (actual)2021-12-06Date precision: day

Registry last updated2023-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

QPOPDEVICE

Sponsors & collaborators

National University Hospital, Singaporelead sponsor

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05177432 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.